Analytics & Preformulation
PepTalk's Analytics & Preformulation Pipeline explores the intersection of predictive modeling, formulation science, and analytical innovation in the early development of novel biologics. As the complexity and diversity of biotherapeutic modalities expand, the integration of artificial intelligence, strategic formulation, and robust analytical platforms has become essential for accelerating development timelines and ensuring clinical success. The future of Immunogenicity prediction begins with cutting-edge tools for predicting specific immune responses in early-stage development. The analytical landscape focuses on the modalities of bispecifics, ADCs, fusion proteins, peptides and RNA-based therapeutics. Predicting and mitigating aggregation risk involves strategies for early screening and biophysical characterization. Join to explore the future of this dynamic field.
January 19
January 20-21
January 21-22
KEYNOTE & FEATURED PRESENTATIONS:
Application and Opportunities for AI/ML in Immunogenicity Risk Prediction
Timothy Hickling, PhD, Former, Investigative & Immunosafety Chapter, Roche
Rapid Development of Dual-specific Antibody Therapeutics Using AI-driven Design with High-Throughput Cell-based Binding and SPR Analyses
Jack Hu, PhD, Director, Aureka Bio
Mechanisms of Near-UV and Visible-Light Degradation of Therapeutics Proteins
Christian Schoeneich, PhD, Takeru Higuchi Distinguished Professor & Chair, Pharmaceutical Chemistry, University of Kansas Lawrence
If you are working in the following areas join the PepTalk community:
- Analytical Sciences
- Analytical Chemistry
- Analytical Development
- Analytical Development
- Analytical Operations
- Analytical Science & Technology
- Applied Spectroscopy
- Assay Development
- Biologics Technical Development
- Bioprocess Development
- Bioprocessing
- Cell Therapy R&D
- CMC
- Early CMC & Analytical
- Gene Therapy R&D
- Manufacturing Science & Technology (MSAT)
- Mass Spectrometry
- Protein Analytical Chemistry
- Protein Biochemistry
- Quality Control
- R&D
- Technical Development